← 返回

免疫细胞浸润作为子宫内膜癌预后因素:一项 meta 分析

英文原题:Immune cell infiltration as a prognostic factor in endometrial cancer: a meta-analysis.

查看英文原题

Immune cell infiltration as a prognostic factor in endometrial cancer: a meta-analysis.

PubMed 2025/03/15(内容时间) Am J Cancer Res Q2 · IF 3.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

免疫系统在癌症发生和进展中的作用日益受到关注。子宫内膜癌作为常见的妇科恶性肿瘤,对免疫治疗显示出良好的应答。本研究旨在评估各种免疫细胞亚群在子宫内膜癌中的预后意义,重点关注潜在的新型生物标志物和治疗靶点。进行了系统性文献综述和meta分析。共纳入11项符合条件的研究,包含2,319例子宫内膜癌患者。主要结局是免疫细胞类型水平,特别是CD8+ T细胞,与总体预后之间的关联。meta分析发现,高水平的TIL(肿瘤浸润淋巴细胞)(TILs),特别是CD8+ T细胞,与子宫内膜癌患者更好的总体预后显著相关。这些发现表明,肿瘤免疫微环境在子宫内膜癌预后中起着至关重要的作用。本meta分析表明,肿瘤微环境中较高水平的CD8+ T细胞与子宫内膜癌预后改善相关,凸显了免疫系统在预后判断和治疗中的潜力。

展开英文摘要原文

The immune system's role in cancer development and progression is receiving increasing attention. Endometrial cancer, common gynecological malignancy, has exhibited promising responses to immunotherapies.

This study aims to assess the prognostic significance of various immune cell subsets in endometrial cancer, focusing on potential novel biomarkers and therapeutic targets. A systematic literature review and meta-analysis were conducted. Eleven eligible studies, comprising 2,319 patients with endometrial cancer, were included.

The primary outcome was the association between levels of immune cell types, particularly CD8+ T cells, and overall prognosis. The meta-analysis found that high levels of tumor-infiltrating lymphocytes (TILs), particularly CD8+ T cells, were significantly associated with better overall prognosis in endometrial cancer patients.

These findings suggest that the tumor immune microenvironment plays a crucial role in endometrial cancer prognosis. This meta-analysis indicates that higher levels of CD8+ T cells in the tumor microenvironment are linked to improved prognosis in endometrial cancer, underscoring the immune system's potential in prognostication and therapy.

论文信息

作者
Lin Y、Lin Q、Guan Q、Chen D、Zhou Y、Li S
单位
Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital Fuzhou 350014, Fujian, PR China.China
期刊
American journal of cancer research2025
原文标识
PubMed 40226477 · DOI 10.62347/BXZM8857